Trifluoperazine, an Antipsychotic Drug, Effectively Reduces Drug Resistance in Cisplatin-Resistant Urothelial Carcinoma Cells via Suppressing Bcl-xL: An In Vitro and In Vivo Study

Cisplatin-based chemotherapy is the primary treatment for metastatic bladder urothelial carcinoma (UC). Most patients inevitably encounter drug resistance and resultant disease relapse. Reduced apoptosis plays a critical role in chemoresistance. Trifluoperazine (TFP), an antipsychotic agent, has dem...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuo, Kuan-Lin, Liu, Shing-Hwa, Lin, Wei-Chou, Hsu, Fu-Shun, Chow, Po-Ming, Chang, Yu-Wei, Yang, Shao-Ping, Shi, Chung-Sheng, Hsu, Chen-Hsun, Liao, Shih-Ming, Chang, Hong-Chiang, Huang, Kuo-How
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6651283/
https://www.ncbi.nlm.nih.gov/pubmed/31262032
http://dx.doi.org/10.3390/ijms20133218

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6651283/
https://www.ncbi.nlm.nih.gov/pubmed/31262032
http://dx.doi.org/10.3390/ijms20133218

Ejemplares similares